Melanotan II 10mg Peptide | Alpha-MSH Analog Research |

⚠️ ATTENTION: STRICTLY FOR LABORATORY RESEARCH USE ONLY. This product is NOT FOR HUMAN CONSUMPTION, medical use, veterinary use, or diagnostic use. By purchasing, you agree to handle this compound in compliance with all local and federal regulations.

The Apex of Melanocortin Signaling & Photoprotective Research

Melanotan II (MT-2) represents the absolute pinnacle of laboratory research concerning dermal pigmentation, neuroendocrine signaling, and metabolic energy homeostasis. Originally synthesized at the University of Arizona, this synthetic cyclic heptapeptide analog of the naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH) was engineered to overcome the profound biological limitations of endogenous hormones. In its natural state, alpha-MSH is rapidly degraded by enzymes, possessing a half-life of only several minutes, making it an inviable candidate for sustained research.

The Cyclic Heptapeptide Modification: To solve this rapid metabolic clearance and create a stable compound for longitudinal study, molecular biologists developed the cyclic structure of Melanotan II. This advanced synthetic analog features a specific sequence—Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2—that incorporates two critical modifications which fundamentally alter its pharmacokinetics:

• The Cyclic Ring Structure: Unlike the linear Melanotan I, MT-2 is cyclized, which dramatically increases its structural rigidity and protects the peptide bonds from enzymatic proteolysis.

• D-Phenylalanine Substitution: The inclusion of D-Phe in the fourth position enhances its binding affinity and selectivity across multiple melanocortin receptors.

These precise structural alterations effectively render the molecule highly resistant to degradation. Because it successfully evades rapid metabolic breakdown, the biological half-life of Melanotan II is radically extended, allowing for sustained receptor activation in in-vitro and in-vivo models. Furthermore, its binding potency is exponentially higher than baseline alpha-MSH, making it an extraordinarily powerful tool for investigating the melanocortin system’s role in systemic resilience.

The Biochemistry of Melanogenesis & Neuroendocrine Flux

Unlike localized topical agents that rely on superficial absorption, Melanotan II acts as a systemic master signaling molecule. It forcefully initiates a biological cascade by interacting with the G-protein coupled melanocortin receptors distributed throughout the skin and the central nervous system.

Receptor Synergy Matrix: MC1R through MC5R

When introduced into a research model, Melanotan II serves as a non-selective agonist with high affinity for the following critical pathways:

1. MC1R (Dermal Pigmentation): Binding to the Melanocortin 1 Receptor on melanocytes triggers the activation of the enzyme tyrosinase. This enzyme catalyzes the conversion of the amino acid tyrosine into eumelanin (the dark, photoprotective pigment), rather than the lighter pheomelanin.

2. MC4R (Metabolic & Satiety Signaling): MT-2 crosses the blood-brain barrier and binds to MC4 receptors in the hypothalamus. This interaction is the primary biological engine driving appetite suppression and lipid metabolism, offering a window into how the brain regulates systemic energy expenditure.

3. CNS Arousal Pathways: Through its interaction with MC3 and MC4 receptors in the central nervous system, MT-2 influences the neural circuitry responsible for sexual arousal and erectile function, bypassing traditional vascular mechanisms in favor of neurochemical signaling.

Mechanism of Eumelanin Upregulation (The Biological Shield)

One of the most profoundly studied mechanisms of Melanotan II is its ability to induce melanogenesis independently of high-level UV radiation. In traditional models, UV exposure causes DNA damage, which then triggers alpha-MSH release as a defense mechanism. MT-2 bypasses this damaging “trigger” phase. By providing a direct chemical signal to the MC1R, it activates the cyclic adenosine monophosphate (cAMP) pathway, leading to the rapid synthesis of eumelanin. This process not only darkens the tissue but physically increases the cell’s capacity for photoprotection, effectively creating a “biological armor” against ionizing radiation.

Primary Domains of Laboratory Investigation

1. Dermal Photoprotection & Carcinogenesis Research

In dermatological and oncological research models, Melanotan II is intensely investigated for its unmatched ability to stimulate protective pigmentation. By forcing the synthesis of eumelanin, it allows researchers to study the prevention of UV-induced DNA mutations and the potential for mitigating skin cancer risk in high-sensitivity phenotypes.

(Evidence Level: ⭐⭐⭐⭐⭐ – Supported by extensive clinical and cellular data).

2. Metabolic Energy Homeostasis & Satiety Signaling

Within the Incretin & Metabolic Research framework, MT-2 is utilized to study the hypothalamic “satiety switch.” Researchers observe how MC4R activation reduces food intake and increases metabolic rate, providing critical data on the treatment of obesity and insulin resistance through non-incretin pathways.

(Evidence Level: ⭐⭐⭐⭐☆).

3. Neurobehavioral Pathways: Libido & Sexual Motivation

Beyond external tissue changes, Melanotan II possesses profound neurobehavioral properties. Studies suggest that MT-2 administration directly enhances the brain’s processing of sexual stimuli by activating melanocortin pathways in the medial preoptic area and the paraventricular nucleus. This makes it a cornerstone for research into neurogenic sexual dysfunction.

(Evidence Level: ⭐⭐⭐⭐☆).

4. Systemic Hormonal Resilience & Redox Balance

Emerging research explores MT-2’s role in modulating systemic inflammation and oxidative stress. As a hormone analog, it is studied for its capacity to restore “Hormonal Resilience” by balancing the feedback loops between the pituitary gland and peripheral tissues, particularly during periods of metabolic or environmental stress.

(Evidence Level: ⭐⭐⭐☆☆).

Comparative Advantage: MT-2 vs Linear alpha-MSH Analogs

In advanced endocrine research, scientists must choose between utilizing linear analogs (like Melanotan I) or cyclic compounds like MT-2. While Melanotan I is more selective for the MC1R (skin only), it lacks the metabolic and neurological reach of MT-2.

Melanotan II provides a Triple-Action Research Profile:

• Stability: The cyclic structure ensures a significantly longer duration of action, requiring lower concentrations to achieve receptor saturation.

• CNS Penetration: Unlike many peptides, MT-2 effectively traverses the blood-brain barrier, allowing for the study of hypothalamic and neurological pathways.

• Synergistic Utility: It allows for the simultaneous study of pigmentation, appetite, and arousal within a single research model, making it the most versatile melanocortin research peptide currently available.

Laboratory Specifications & Compound Profile

This ultra-premium formulation is synthesized for rigorous laboratory environments demanding absolute molecular stability, high purity, and sustained receptor binding affinity across the MC1R-MC5R spectrum.

• Product Classification: Synthetic Cyclic Heptapeptide / Melanocortin Agonist.

• Amino Acid Sequence: Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-NH2.

• Molecular Weight: 1024.2 g/mol.

• Dosage / Yield: High-Purity 10mg (10000mcg).

• Storage Requirements: Store lyophilized powder at -20°C for long-term stability. Avoid repeated freeze-thaw cycles.

• Purity Standard: 99%+ (Independent Third-Party Lab Verified for structural integrity, correct cyclization, and receptor binding affinity).